<DOC>
	<DOC>NCT00351325</DOC>
	<brief_summary>The purpose of this study is to assess the safety and tolerability of multiple escalating doses of BMS-663513 when given in combination with paclitaxel and carboplatin.</brief_summary>
	<brief_title>A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Good activity level Life expectancy of â‰¥ 6 months Solid tumor malignancy for which paclitaxel and carboplatin are appropriate Major surgery within 4 weeks Any concurrent cancer History of autoimmune diseases Symptomatic bowel obstruction Continued use of steroids Symptomatic brain metastases Current nerve damage in fingers/toes Positive for HIV, hepatitis B/C White blood cells &lt; 3,000 Hemoglobin &lt; 9 Platelets &lt; 100,000 ALT/AST and/or alkaline phosphatase &gt;= 2.5 x ULN Creatine &gt; 1.5 Prior BMS663513</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>